Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Journal of Oncology Practice
|
January 3, 2012
Need for global partnership in cancer care: perceptions of cancer care researchers attending the 2010 australia and Asia pacific clinical oncology research development workshop
H Kim Lyerly, Amy P Abernethy, Martin R Stockler, et al.
Current Medical Research and Opinion
|
January 26, 2010
Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer
Beth Sherrill, Angelo Di Leo, Mayur M Amonkar, et al.
Eclinicalmedicine
|
June 13, 2025
Modelling the potential financial impacts of expanding access to immune checkpoint inhibitors as monotherapy for treating advanced non-small cell lung cancer
Kiu Tay-Teo, Dario Trapani, Manju Sengar, et al.
The Lancet. Oncology
|
May 12, 2009
Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial
Steven M Grunberg, Janusz Rolski, Janos Strausz, et al.
The Breast Journal
|
January 25, 2006
Breast cancer in limited-resource countries: treatment and allocation of resources
Alexandru Eniu, Robert W Carlson, Zeba Aziz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy
Jørn Herrstedt, Wichit Apornwirat, Ahmed Shaharyar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
May 2, 2022
A Multicenter Study of Clinical Presentations and Outcomes of Multiple Myeloma in Pakistan: The Real-World Analysis in a Resource-Constrained Country
Nadia Saeed, Usman Ahmad, Munira Moosajee, et al.
The Oncologist
|
April 19, 2015
Regional variation in identified cancer care needs of early-career oncologists in China, India, and Pakistan
H Kim Lyerly, Maria R Fawzy, Zeba Aziz, et al.
Cancer Biology & Therapy
|
March 10, 2017
Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression
Afia Muhammad Akram, Zafar Iqbal, Tanveer Akhtar, et al.
Plos One
|
April 21, 2022
"Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan"
Adeeba Zaki, Salman Muhammad Soomar, Danish Hasan Khan, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Journal of Oncology Practice
|
January 3, 2012
Need for global partnership in cancer care: perceptions of cancer care researchers attending the 2010 australia and Asia pacific clinical oncology research development workshop
H Kim Lyerly, Amy P Abernethy, Martin R Stockler, et al.
Current Medical Research and Opinion
|
January 26, 2010
Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer
Beth Sherrill, Angelo Di Leo, Mayur M Amonkar, et al.
Eclinicalmedicine
|
June 13, 2025
Modelling the potential financial impacts of expanding access to immune checkpoint inhibitors as monotherapy for treating advanced non-small cell lung cancer
Kiu Tay-Teo, Dario Trapani, Manju Sengar, et al.
The Lancet. Oncology
|
May 12, 2009
Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial
Steven M Grunberg, Janusz Rolski, Janos Strausz, et al.
The Breast Journal
|
January 25, 2006
Breast cancer in limited-resource countries: treatment and allocation of resources
Alexandru Eniu, Robert W Carlson, Zeba Aziz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy
Jørn Herrstedt, Wichit Apornwirat, Ahmed Shaharyar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
May 2, 2022
A Multicenter Study of Clinical Presentations and Outcomes of Multiple Myeloma in Pakistan: The Real-World Analysis in a Resource-Constrained Country
Nadia Saeed, Usman Ahmad, Munira Moosajee, et al.
The Oncologist
|
April 19, 2015
Regional variation in identified cancer care needs of early-career oncologists in China, India, and Pakistan
H Kim Lyerly, Maria R Fawzy, Zeba Aziz, et al.
Cancer Biology & Therapy
|
March 10, 2017
Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression
Afia Muhammad Akram, Zafar Iqbal, Tanveer Akhtar, et al.
Plos One
|
April 21, 2022
"Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan"
Adeeba Zaki, Salman Muhammad Soomar, Danish Hasan Khan, et al.
Page
of 5